SMALL BUSINESS SET ASIDE - TOTAL

COMPREHENSIVE DRUG TESTING, INC. - DCF DRUG TESTING BPA CALL

PIID: 2031ZA26F00190
Signed Date: Mar 11, 2026Effective Date: Mar 11, 2026End Date: Closed on Sep 30, 2026
Award $
$52K
Vendor
COMPREHENSIVE DRUG TESTING, INC.
NAICS
541380
Signed Date
Mar 11, 2026

Key Details

Dollars Obligated
$52,165
Base & All Options
$52,165
Awarding Sub-Agency
Bureau of Engraving and Printing
Parent IDIQ (PIID)
2031ZA23A00011
Product Service Code
Q301 - REFERENCE LABORATORY TESTING
Extent Competed
COMPETED UNDER SAP
Number of Offers
1
Place of Performance
WASHINGTON, DC

Description

DCF DRUG TESTING BPA CALL

Context & Analysis

On Mar 11, 2026, Department of the Treasury obligated $52,165 to COMPREHENSIVE DRUG TESTING, INC. for dcf drug testing bpa call. The award is classified under NAICS 541380 — TESTING LABORATORIES AND SERVICES. Competition extent: competed under sap with 1 offer received. The procurement used a SMALL BUSINESS SET ASIDE - TOTAL set-aside. Performance is located in WASHINGTON, DC. This award is one of several similar procurements from Department of the Treasury under NAICS 541380 — related awards are listed below.

Contractor Information

UEI: YM54JZGNDGC5
Location: IRVINE, CA
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related